UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

The Quigley Corporation
(Name of Issuer)
 
Common Stock, par value $.0005 per share
(Title of Class of Securities)
 
74838L304
(CUSIP Number)
 
Aron Izower
Reed Smith LLP
599 Lexington Ave.
New York, New York 10022
(212) 549-0393
 
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
April 28, 2009
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box  ¨ ..

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.
 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information, which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
 

CUSIP No.     74838L304
  
Page    2     of   8  Pages

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Ted Karkus
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)            (a) ¨
                                                             (b) x
3
SEC USE ONLY
 
4
SOURCE OF FUNDS (see Instructions)
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                                                                                                                         ¨
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
USA
 
NUMBER OF
 
7
SOLE VOTING POWER
 
620,850
SHARES
 
BENEFICIALLY
 
    8    
SHARED VOTING POWER
 
0
   OWNED BY EACH   
 
REPORTING
9
SOLE DISPOSITIVE POWER
 
620,850
 
  PERSON WITH
10
SHARED DISPOSITIVE POWER
 
0
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
620,850
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)                                                                                                                                                              ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
4.8%
14
TYPE OF REPORTING PERSON (see Instructions)
 
IN

 
 
 
 
CUSIP No.     74838L304
  
Page    3     of   8  Pages

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Mark Burnett
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)            (a) ¨
                                                             (b) x
3
SEC USE ONLY
 
4
SOURCE OF FUNDS (see Instructions)
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                                                                                                                         ¨
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
USA
 
NUMBER OF
 
7
SOLE VOTING POWER
 
151,473
SHARES
 
BENEFICIALLY
 
    8    
SHARED VOTING POWER
 
0
   OWNED BY EACH   
 
REPORTING
9
SOLE DISPOSITIVE POWER
 
151,473
 
  PERSON WITH
10
SHARED DISPOSITIVE POWER
 
0
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
151,473
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)                                                                                                                                                              ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
1.2%
14
TYPE OF REPORTING PERSON (see Instructions)
 
IN
 
 
CUSIP No.     74838L304
  
Page    4     of   8  Pages

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
John DeShazo
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)            (a) ¨
                                                             (b) x
3
SEC USE ONLY
 
4
SOURCE OF FUNDS (see Instructions)
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                                                                                                                         ¨
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
USA
 
NUMBER OF
 
7
SOLE VOTING POWER
 
277,000
SHARES
 
BENEFICIALLY
 
    8    
SHARED VOTING POWER
 
0
   OWNED BY EACH   
 
REPORTING
9
SOLE DISPOSITIVE POWER
 
277,000
 
  PERSON WITH
10
SHARED DISPOSITIVE POWER
 
0
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
277,000
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)                                                                                                                                                              ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
2.1%
14
TYPE OF REPORTING PERSON (see Instructions)
 
IN
 
 

CUSIP No.     74838L304
  
Page    5     of   8  Pages

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Louis Gleckel, MD
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)            (a) ¨
                                                             (b) x
3
SEC USE ONLY
 
4
SOURCE OF FUNDS (see Instructions)
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                                                                                                                         ¨
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
USA
 
NUMBER OF
 
7
SOLE VOTING POWER
 
20,000
SHARES
 
BENEFICIALLY
 
    8    
SHARED VOTING POWER
 
0
   OWNED BY EACH   
 
REPORTING
9
SOLE DISPOSITIVE POWER
 
20,000
 
  PERSON WITH
10
SHARED DISPOSITIVE POWER
 
0
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
20,000
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)                                                                                                                                                              ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
0.1%
14
TYPE OF REPORTING PERSON (see Instructions)
 
IN
 

CUSIP No.     74838L304
  
Page    6     of   8  Pages

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Mark Leventhal
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)            (a) ¨
                                                             (b) x
3
SEC USE ONLY
 
4
SOURCE OF FUNDS (see Instructions)
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                                                                                                                         ¨
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
USA
 
NUMBER OF
 
7
SOLE VOTING POWER
 
240,000
SHARES
 
BENEFICIALLY
 
    8    
SHARED VOTING POWER
 
0
   OWNED BY EACH   
 
REPORTING
9
SOLE DISPOSITIVE POWER
 
240,000
 
 
  PERSON WITH
10
SHARED DISPOSITIVE POWER
 
0
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
240,000
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)                                                                                                                                                              ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
1.9%
14
TYPE OF REPORTING PERSON (see Instructions)
 
IN
 
 
CUSIP No.     74838L304
  
Page    7     of   8  Pages
 
This Amendment No. 1 (this “Amendment”) relates to the Schedule 13D filed by Ted Karkus, Mark Burnett, John DeShazo, Louis Gleckel, MD, and Mark Leventhal (together, the “Reporting Persons”) with the Securities and Exchange Commission on April 7, 2009 (the “Schedule 13D”), relating to shares of common stock, par value $0.0005 per share, of The Quigley Corporation (the “Company”).
 
Neither the fact of this filing nor anything contained herein shall be deemed an admission by the Reporting Persons that they constitute a “group” as such term is used in Section 13(d)(1)(k) of the rules and regulations under the Securities Exchange Act of 1934, as amended.
 
Items 4 and 7 of the Schedule 13D are hereby amended and supplemented as follows:

ITEM 4.  PURPOSE OF TRANSACTION

On April 23, 2009, The Quigley Corporation filed an action in the United States District Court for the Eastern District of Pennsylvania against Ted Karkus, John Edmunds Ligums, Sr. (“Ligums”), Mark Burnett, John DeShazo, Louis Gleckel, MD and Mark Leventhal (collectively, the “Defendants”), asserting claims for violations of Sections 13(d), 14(a) and 16(a) of the Securities Exchange Act of 1934, as amended.

The Reporting Persons believe the claims are baseless and intend to vigorously defend against them.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

The following exhibits are filed with this Amendment.

Exhibit  99.1.  Complaint of The Quigley Corporation against the Defendants dated April 23, 2009.
 
 
CUSIP No.     74838L304
  
Page    8     of   8  Pages
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Schedule 13D is true, complete and correct.
 
Dated:
April 28, 2009
/s/ Ted Karkus
  
   
By:  Ted Karkus
  
       
       
Dated:
April 28, 2009
/s/ Mark Burnett
  
   
By:  Mark Burnett
  
       
       
Dated:
April 28, 2009
/s/ John DeShazo
  
   
By:  John DeShazo
  
       
       
Dated:
April 28, 2009
/s/ Louis Gleckel, M.D.
  
   
By:  Louis Gleckel, M.D.
  
       
       
Dated:
April 28, 2009
/s/ Mark Leventhal
  
   
By:  Mark Leventhal